Growth Metrics

Gilead Sciences (GILD) Total Debt (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -11.08%
Dec 31, 2025 -0.02%
Sep 30, 2025 -0.02%
Jun 30, 2025 -0.02%
Mar 31, 2025 -6.59%
Dec 31, 2024 14.89%
Sep 30, 2024 -0.43%
Jun 30, 2024 -7.32%
Mar 31, 2024 0.83%
Dec 31, 2023 0.02%
Sep 30, 2023 -1.05%
Jun 30, 2023 0.03%
Mar 31, 2023 0.04%
Dec 31, 2022 0.03%
Sep 30, 2022 -3.79%
Jun 30, 2022 0.03%
Mar 31, 2022 -1.82%
Dec 31, 2021 -3.58%
Sep 30, 2021 -8.25%
Jun 30, 2021 0.03%
Mar 31, 2021 -3.94%
Dec 31, 2020 7.21%
Sep 30, 2020 21.53%
Jun 30, 2020 0.02%
Mar 31, 2020 -2.02%
Dec 31, 2019 0.02%
Sep 30, 2019 -5.73%
Jun 30, 2019 -1.86%
Mar 31, 2019 -2.72%
Dec 31, 2018 0.02%
Sep 30, 2018 -6.00%
Jun 30, 2018 0.02%
Mar 31, 2018 -13.38%
Dec 31, 2017 14.63%
Sep 30, 2017 11.28%
Jun 30, 2017 -0.09%
Mar 31, 2017 -0.09%
Dec 31, 2016 -2.68%
Sep 30, 2016 22.34%
Jun 30, 2016 -3.05%
Mar 31, 2016 3.48%
Dec 31, 2015 -0.76%
Sep 30, 2015 81.07%
Jun 30, 2015 -0.72%
Mar 31, 2015 -0.33%
Dec 31, 2014 31.82%
Sep 30, 2014 -0.99%
Jun 30, 2014 -3.05%
Mar 31, 2014 47.74%
Dec 31, 2013 -9.26%
Sep 30, 2013 -0.33%
Jun 30, 2013 -8.25%
Mar 31, 2013 -2.75%
Dec 31, 2012 -6.24%
Sep 30, 2012 -3.60%
Jun 30, 2012 -3.50%
Mar 31, 2012 23.94%
Dec 31, 2011 95.39%
Sep 30, 2011 0.39%
Jun 30, 2011 -13.88%
Mar 31, 2011 29.22%
Dec 31, 2010 451.07%
Mar 31, 2010 26.87%
Dec 31, 2009 -97.28%
Sep 30, 2009 -49.31%